Navigation Links
Gardasil Demonstrates Up to 100% Efficacy

- In the Prevention of Cervical Cancer and Other Human Papillomavirus Related Diseases After an Additional Year of Follow Up in Large Phase III Clinical Studies Which Included More Than 17,000 Women

New England Journal of Medicine publishes the most comprehensive and robust clinical data for any Human Papillomavirus vaccine

LYON, France, 10th May2007 – New clinical study results confirm the high and sustained efficacy of Gardasil® in the prevention of cervical cancer and other Human Papillomavirus related diseases that occur before cervical cancer and beyond the cervix. After three years of follow up in the large phase III clinical studies FUTURE I and II, which included more than 17,000 women, Gardasil® prevented 98% to 100% of pre-cancerous and potentially pre-cancerous cervical lesions (CIN 1-3), pre-cancerous and potentially pre-cancerous vulvar and vaginal lesions (VaIN 1-3 and VIN 1-3), and genital warts caused by Human Papillomavirus types 6, 11, 16 and 18. The results were published today in the New England Journal of Medicine (NEJM). ,

The new three years results substantiate previous phase III results which demonstrated up to 100% efficacy against the same diseases after two years of follow up and on which the licensure of Gardasil® was essentially based. The results also add to other recently presented three years phase III data. The currently available phase III results for Gardasil® are the most comprehensive and robust clinical data presented for any Human Papillomavirus vaccine. Previously presented data from a phase II study had shown Gardasil® to be 100% efficacious against cervical lesions and genital warts after five years of follow up post-enrolment. ,a)

"The efficacy results on which the licensure of Gardasil® was based, were already excellent and very reliable. The new data clearly demonstrate that this high efficacy is likely to persist for a long time. The gap in
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data Published in The Lancet Show Gardasil was 100 Percent Effective in Preventing High-Grade Vulvar and Vaginal Lesions Caused by HPV Types 16 and 18
2. New England Journal of Medicine Publishes New Data on Gardasil, Mercks Cervical Cancer Vaccine
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
5. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
6. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
7. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
8. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
9. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
10. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
11. Introgens Advexin Demonstrates Clinical Benefit in Inherited Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Gardasil Demonstrates Efficacy
(Date:7/31/2015)... 31, 2015  Seeger Weiss LLP is reporting that on ... warning letter to C.R. Bard, the manufacturer of Inferior ... to correct violations the agency found at two of Bard,s ... the FDA cited them during Inspectional Observations that occurred on ... Tempe, AZ , location and on October 6, ...
(Date:7/31/2015)... 31, 2015  Boston Children,s Hospital physicians report ... printing of their anatomy before undergoing high-risk brain ... (abnormalities in the brain,s blood vessels) that posed ... in the Journal of Neurosurgery: Pediatrics , ... and synthetic resins to create custom, high-fidelity models ...
(Date:7/31/2015)... PORTLAND, Ore., July 31, 2015  Semler Scientific, Inc. ... and testing services to healthcare insurers and physician groups, ... June 30, 2015. "In the second ... over year revenue growth of 54%, quarter over quarter ... of the installed base of FloChec® units of 18%," ...
Breaking Medicine Technology:Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 2Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 33D Printing Helps Doctors Rehearse Complex Brain Procedures 23D Printing Helps Doctors Rehearse Complex Brain Procedures 33D Printing Helps Doctors Rehearse Complex Brain Procedures 4Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6
... A number of costs associated with nonprescription drug ... and a half years. Certain material costs for plastic ... during this time, increasing packaging expenses. Advertising and marketing ... the majority of marketers reduced advertising costs in 2009, ...
... ERT (Nasdaq: ERES ) announced today ... 2010 on Thursday, November 4, 2010, after the market closes. ... at 5:00 PM EDT that day. For ... within the United States or 1-412-858-4600 when calling internationally. There ...
Cached Medicine Technology:Nonprescription Drugs Cost Structures Fluctuate with Increased Cost of Goods, According to Kline 2Nonprescription Drugs Cost Structures Fluctuate with Increased Cost of Goods, According to Kline 3ERT to Announce Third Quarter 2010 Results on November 4, 2010 2
(Date:8/3/2015)... Hollywood, FL (PRWEB) , ... ... ... internet’s most-visited bodybuilding and fitness site and the largest online retailer of ... Supplement Awards. BPI Sports is up for 11 awards in the following ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... of its industry-defining contract lifecycle management solution, as well as announced the date ... increase the speed and ease of contract management tasks as well as enhancements ...
(Date:8/3/2015)... ... August 03, 2015 , ... AxoGen, Inc. (NASDAQ: AXGN), a leader in developing ... the Wedbush Healthcare Conference on Wednesday, August 12, 2015 at 9:45am (ET) at Le ... of the Company’s presentation may be accessed via the investor relations section of the ...
(Date:8/3/2015)... ... August 03, 2015 , ... The U.S. Food and Drug ... Kybella is similar to deoxycholic acid, which occurs naturally in the body and helps ... to treat this area of the body. These are invasive procedures and very expensive ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... predicted to decline by 39 percent, according to market research compiled for the ... data from the U.S. Department of Labor, Bureau of Labor Statistics. As the ...
Breaking Medicine News(10 mins):Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 2Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 3Health News:Novatus Unveils Milestone Software Release 2Health News:AxoGen, Inc. to Present at the Wedbush Healthcare Conference 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 3Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 2Health News:Dental Association Announces Impending Reduction of Dental Laboratories Could Impact Dentists 3
... Dec. 17 HealthSouth,Corporation (NYSE: HLS ) today ... EST on Tuesday, Feb. 24, 2009, to discuss its results ... The conference call may ... 76626362. International callers should dial (973) 582-2847 and,give the same ...
... ATLANTA, Dec. 17, 2008, The AMERIGROUP Foundation announced ... Outreach worker at West End Medical Centers, by designating ... Ms. Roper has contributed significantly to the ... years of extensive neighborhood involvement. For the past ...
... those with pulmonary clots saw benefit, , , WEDNESDAY, Dec. ... the clot-dissolving drug tenecteplase (TKNase) to people with sudden ... a form of tissue plasminogen activator (tPA), didn,t work ... up on the idea. , "In specific situations, those ...
... 17 Human Pheromone,Sciences, Inc. (OTC Bulletin Board: EROX) ... Comprehensive Patent Application with the U.S. Patent and,Trademark Office ... with its origin in sea coral, which has significant ... positive social relationships,personal well-being and social attraction. , ...
... request of the presidential transition team, ideas on advancing ... today by the American College of Physicians (ACP). ... student members. It is the nation,s largest medical ... membership organization. , "ACP believes that it is essential ...
... leader in the planning and development of sustainable, social and ... Dr. Theresa Ramsey,s Center For Natural Healing to create OTP2 ... the focus of the collaboration - to provide consulting services ... , , OTP2 brings together ...
Cached Medicine News:Health News:HealthSouth Announces Date of 2008 Fourth Quarter and Year-End Earnings Conference Call 2Health News:Fredericka Roper of Atlanta Honored as 'Healthy Hero' By the AMERIGROUP Foundation 2Health News:Clot Dissolver Doesn't Boost Survival in Cardiac Arrest Patients 2Health News:Clot Dissolver Doesn't Boost Survival in Cardiac Arrest Patients 3Health News:HPS Files Patent for Mood-Enhancing Compound Naturally Found in Sea Coral 2Health News:Internists ask President-elect Obama to include aid for primary care in stimulus proposal 2Health News:Internists ask President-elect Obama to include aid for primary care in stimulus proposal 3Health News:Pyramid Developers and Dr. Ramsey's Center for Natural Healing Announce Formation of Community Health and Wellness Planning Collaborative. 2Health News:Pyramid Developers and Dr. Ramsey's Center for Natural Healing Announce Formation of Community Health and Wellness Planning Collaborative. 3Health News:Pyramid Developers and Dr. Ramsey's Center for Natural Healing Announce Formation of Community Health and Wellness Planning Collaborative. 4
... might just be the world's most versatile ... support, post-op/rehab support, or both, Flex is ... Accutrac™ ROM hinges control flexion and extension ... durability while being heat-moldable to accommodate changes ...
... The Drytex Adjustable Patella Donut is ... unique nylon core and polyester Lycra ... A trimable full-circumference donut provides for ... have neoprene based allergies or irritations. ...
... The cool version of the TROM ... range-of-motion and locking capabilities as the full ... warmer climates. The ease of use and ... a variety of protocols following major ligament ...
Provides range-of-motion control for both flexion and extension along with a drop lock feature...
Medicine Products: